APA (7th ed.) Citation

Atsmon, J., Brill-Almon, E., Nadri-Shay, C., Chertkoff, R., Alon, S., Shaikevich, D., . . . Shaaltiel, Y. (2015). Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R. Toxicology and applied pharmacology, 287(3), 202-209. https://doi.org/10.1016/j.taap.2015.06.004

Chicago Style (17th ed.) Citation

Atsmon, Jacob, et al. "Preclinical and First-in-human Evaluation of PRX-105, a PEGylated, Plant-derived, Recombinant Human Acetylcholinesterase-R." Toxicology and Applied Pharmacology 287, no. 3 (2015): 202-209. https://doi.org/10.1016/j.taap.2015.06.004.

MLA (9th ed.) Citation

Atsmon, Jacob, et al. "Preclinical and First-in-human Evaluation of PRX-105, a PEGylated, Plant-derived, Recombinant Human Acetylcholinesterase-R." Toxicology and Applied Pharmacology, vol. 287, no. 3, 2015, pp. 202-209, https://doi.org/10.1016/j.taap.2015.06.004.